Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory

Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory

Several studies reported an increase in cardiovascular risk (CVR) in women with polycystic ovary syndrome (PCOS), considered primarily as the result of the combination of all the clinical features that characterize the syndrome, including hyperandrogenism, insulin resistance, diabetes, obesity chron...

Full description

Bibliographic Details
Main Authors: Giuseppe Annunziata, Roberto Ciampaglia, Xavier Capò, Fabrizia Guerra, Antoni Sureda, Gian Carlo Tenore, Ettore Novellino
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Polycystic ovary syndrome
Trimethylamine N-oxide
Cardiovascular risk
Microbiota
Dysbiosis
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221009550

Internet

http://www.sciencedirect.com/science/article/pii/S0753332221009550

Similar Items